bioXXmed AG (FRA:T5O)
0.8100
+0.0400 (5.19%)
Last updated: Jul 15, 2026, 4:24 PM CET
bioXXmed AG Revenue
In the year 2025, bioXXmed AG had annual revenue of 16.73K EUR with 378.99% growth. bioXXmed AG had revenue of -269.00 in the half year ending December 31, 2025.
Revenue
16.73K
Revenue Growth
+378.99%
P/S Ratio
12.51
Revenue / Employee
8.37K
Employees
2
Market Cap
209.34K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.73K | 13.24K | 378.99% |
| Dec 31, 2024 | 3.49K | -13.91K | -79.93% |
| Dec 31, 2023 | 17.40K | 5.17K | 42.27% |
| Dec 31, 2022 | 12.23K | -32.39K | -72.59% |
| Dec 31, 2021 | 44.63K | 8.63K | 23.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biotest GmbH & Co. KGaA | 648.90M |
| Novogenia AG | 54.30M |
| Paion AG | 14.81M |
| 2invest AG | 8.89M |
| MagForce AG | 1.08M |
| Biomark Diagnostics | 57.01K |
| co.don AG | 22.00K |